Pendulum Therapeutics
PrivateLast Round
Seed
Feb 6, 2025
Est. Valuation
$175M
Total Funding Raised
$154M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pendulum Therapeutics is a biotechnology company that develops microbiome-targeted interventions and pharmaceuticals to manage chronic illnesses and improve metabolic health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Subscription Commerce, Clinical Trials
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pendulum Therapeutics Comparables
Compare Pendulum Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seed Health | 90% | |
| Viome Life Sciences, Inc. | 81% | |
| Supergut | 78% |
Pendulum Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 6, 2025 | ||||
| Strategic | Jun 27, 2023 | ||||
| Angel | Feb 9, 2023 | ||||
| Series C | Apr 7, 2021 | ||||
| Series B | May 30, 2019 | ||||
Series A | May 30, 2018 |
Pendulum Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series C, Series A, Series B |
| Sequoia Capital | Series C, Series A, Seed, Series B |
| Collaborative Fund | Seed |
| Morgan Noble Healthcare Partners | Series A |
| Mayo Clinic Ventures | Series C, Seed |
| Lowercarbon Capital | Seed |
| Cross Border Impact Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2026
iHerb identified as a key distribution channel.
- May 1, 2026
Reported explosive revenue and customer growth over the last two years.
Recent news
Latest coverage and updates
- hiresJun 25, 2026
Pendulum hired Amy Errett as Board of Directors on Jun 25th '26.
Pendulum Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pendulum Therapeutics's valuation, stock price, and market status.
Is Pendulum a public or private company?
Pendulum is a private company.
What is the current stock price of Pendulum?
Pendulum is a private company with no public stock price. No recent secondary market data is available.
How much is Pendulum worth (valuation)?
Pendulum's valuation is estimated at $175.0M based on funding round data.
Can I buy Pendulum stock?
Pendulum shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pendulum's last funding round?
Pendulum's most recent funding round was Seed on June 27, 2023.
Who are the main investors in Pendulum?
Key investors in Pendulum include Sequoia Capital.
Will Pendulum IPO soon?
No public IPO plans have been announced for Pendulum.
How can I track Pendulum secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pendulum's secondary market activity and sign up for updates.